CLINICAL_TRIALS
trial_result
· 2014-09-12
Clinical Trial Update: Exenatide in Extreme Pediatric Obesity [Phase 2]
Summary
A Phase 2 trial evaluating exenatide in extreme pediatric obesity has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Minnesota | Conditions: Obesity | Phase 2 | Status: COMPLETED | Results posted: 2014-09-12